Shareholder alert: kaskela law llc announces stockholder investigation of nrx pharmaceuticals, inc. and encourages long-term nrxp / brpa investors to contact the firm

Philadelphia--(business wire)--kaskela law llc announces that it is investigating nrx pharmaceuticals, inc. (nasdaq: nrxp) (“nrx”) on behalf of the company's long-term shareholders. nrx is a clinical-stage pharmaceutical company. the current company was formed in may 2021 via a business combination with spac entity big rock partners acquisition corp. (nasdaq: brpa), with nrx as the surviving, publicly traded entity. immediately following the closing of the spac transaction, shares of nrx traded.
NRXP Ratings Summary
NRXP Quant Ranking